MedCity News surveyed over 100 seasoned healthcare benefit consultants for their perspectives on changes in healthcare benefits and employer priorities. The report, sponsored by Quantum Health, highlights the impact of healthcare innovation on the high-cost pharmacy landscape, including the increasing influence of GLP-1 weight-loss drugs. 47% of consultants are advising clients to either expand or decrease coverage of GLP-1s, depending on the client’s needs. Quantum Health's #healthcarenavigation offers guidance and support to both employers and members as they navigate healthcare innovations and assess their ROI impact:https://hubs.ly/Q02DMmB10 Read more key findings of #TheIndex2024 consultant survey: https://hubs.ly/Q02DMr9m0 #EmployeeBenefits #TheIndex2024 #GLP1
Quantum Health’s Post
More Relevant Posts
-
Pharmacy costs remain a top concern for employers, with high-cost drugs in the pipeline and overall cost trends weighing heavily on budgets. As healthcare dollars allocated to pharmacy expenses continue to rise, it's crucial for employers to adopt strategic management approaches. Applied Health Analytics is committed to providing comprehensive solutions to navigate these challenges and ensure affordability for all. #populationhealth #populationhealthassessment #populationhealthdemands #populationhealthinitiatives #populationhealthmanagementservices #populationhealthneeds #populationhealthstrategy #populationwellbeing #providercentricpopulationhealthinitiatives #reducehealthcarecosts
To view or add a comment, sign in
-
-
Happy to share the Surescripts 2023 National Progress Report, with a highlight of the amazing work one pharmacy in particular is doing to bridge healthcare gaps on page 5 - read more about our amazing network alliance here #technology #pharmacy
To view or add a comment, sign in
-
Chief Commercial Officer | Oncology, Rare Diseases, Nuclear Medicine | General Manager, Business Leader within Large and MidSize Organizations
Looking for innovative approaches to cut through the information overload in healthcare? Healthcare Providers, Patients and Payors are increasingly overloaded with information and overwhelmed by the sheer volume of new therapeutic options being approved each year. It's time to re-evaluate our commercialization strategies and prioritize what truly impacts and improves patient health outcomes. Join me at Pharma USA 2024 on Wednesday, March 27th as I participate in a panel discussion on how we can equip commercial teams to effectively communicate the value of products, not just in terms of pills and profit, but in terms of patient well-being. #REpharmaUSA
To view or add a comment, sign in
-
-
Employers and consultants should start discussing strategies on how to navigate the newest class of medications used for weight loss. We dig into potential cost considerations, insight into other reasons these drugs are being prescribed, and ideas to mitigate costs when coverage is offered. Need additional guidance? Reach out to MakoRx for a clinical and financial analysis for your health plan and unique member needs. #healthcare #pharmacy #healthcareinnovation #patientexperience #medical
The 2024 GLP-1 Health Plan Strategy for Employers | MakoRx
https://www.makorx.com
To view or add a comment, sign in
-
Our latest global healthcare M&A report is below and includes the most up to date market insights and intelligence!
DC Advisory’s Healthcare team discusses the revitalized outlook for the sector in our latest DC Discusses article, read in full here > https://bit.ly/4cegNaE Following the highs of global Healthcare M&A in 2021 and 2022, transaction volume in the sector has levelled back to 2016 pre-Covid levels. Our experts share which active sectors are poised to accelerate growth across the US, Europe, and Asia, including: •Medtech •Pharmaceuticals •Social Care •Physician Practice Management (PPM) •Healthcare Services Click the link above to read the full article or get in touch with our global team to discuss further - Rich Blann, Manish Gupta, Hector M. Torres, JD, MBA, Aaron Newman, Frédéric Meyer, Alexandra Nagle, Hoong Wey Woon, Takayuki Tatematsu and wannawut apinanratanakul. #DCAdvisory #Healthcare #Outlook #Valuations #TransactionVolume #Medtech
To view or add a comment, sign in
-
-
In the ongoing transition in health care coverage from paying for volume to paying for value, health technology assessment and value assessment frameworks can serve as important resources for determining the value of pharmaceuticals and other health interventions. AMCP convened key decision makers to explore value assessment needs, tools, and best practices managed care pharmacy professionals need to ensure patients get access to affordable treatments. Access the white paper to learn more! https://bit.ly/49lVJ1f #healthtechnology #valueassessment #managedcare #pharmacy
To view or add a comment, sign in
-
-
We see our life science clients as being called upon to not just witness but actively partake in the shift towards value-based healthcare. The integration of “new” quality competencies within pharma aligns with the value-based care paradigm - offering tangible benefits to health plans, like improved member experiences, lower costs of care, and improved patient outcomes. Let's build a future where quality isn't just a department, but the very essence of strategic and cultural alignment with value-based care focused payers, providers, and health systems. Our end goal? To ensure that our life science clients' innovations lead to a healthier and more equitable healthcare system. In this August 2022 THCQ Insights blog post, Norris provides an overview of this “new” form of quality as a core competency in pharma. Read more here: https://bit.ly/3BQ4NO5 #pharma #valuebasedcare #healthcarequality
To view or add a comment, sign in
-
-
Across the healthcare IT landscape, trends such as the rise of precision medicine and biologics, the utilization of robust health information exchange platforms, and an increased focus on health data management are attracting investor interest. We share more on these trends and other healthcare IT sector insights in our Q1 brief.
Healthcare IT
share.postbeyond.com
To view or add a comment, sign in
-
Across the healthcare IT landscape, trends such as the rise of precision medicine and biologics, the utilization of robust health information exchange platforms, and an increased focus on health data management are attracting investor interest. We share more on these trends and other healthcare IT sector insights in our Q1 brief.
Healthcare IT
share.postbeyond.com
To view or add a comment, sign in
-
Across the healthcare IT landscape, trends such as the rise of precision medicine and biologics, the utilization of robust health information exchange platforms, and an increased focus on health data management are attracting investor interest. We share more on these trends and other healthcare IT sector insights in our Q1 brief.
Healthcare IT
share.postbeyond.com
To view or add a comment, sign in